| Related LncRNAs | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| ID | lncRNA Name | Disease | Method | Sample | Expression pattern | Dysfunction type | Description | PMID | Source |
| EL0570 | HIF1A-AS2 | renal cancer | qPCR etc. | renal cancer tissue | up-regulated | expression | overexpressed in human renal cancer and during hypoxia. | 9923855 | LncRNADisease Lnc2Cancer |
| EL0578 | HOTAIR | renal cancer | qPCR, Western blot, RIP etc. | cell lines (86-O, ACHN) | up-regulated | expression | Long Non-coding RNA HOTAIR Is Targeted and Regulated by miR-141 in Human Cancer Cells. | 24616104 | LncRNADisease Lnc2Cancer |
| EL0853 | MALAT1 | renal cancer | qPCR etc. | clear cell renal cell carcinoma and corresponding noncancerous tissues | up-regulated | interaction | We found that MALAT1 exist a higher fold change (Tumor/Normal) in clear cell kidney carcinoma (KIRC) from The Cancer Genome Atlas (TCGA) Data Portal and a negative correlation with miR-200s family. We further demonstrated MALAT1 promote KIRC proliferation and metastasis through sponging miR-200s in vitro and in vivo. In addition, miR-200c can partly reverse the MALAT1's stimulation on proliferation and metastasis in KIRC. In summary we unveil a branch of the MALAT1/miR-200s/ZEB2 pathway that regulates the progression of KIRC. | 26461224 | Lnc2Cancer |
| EL1102 | PVT1 | renal cancer | N/A | N/A | N/A | mutation | Variants (rs13447075, A>C;rs2648862, A>C) in the plasmacytoma variant translocation gene (PVT1) are associated with end-stage renal disease attributed to type 1 diabetes. | 17881614 | LncRNADisease |